0001181431-12-010793.txt : 20120222 0001181431-12-010793.hdr.sgml : 20120222 20120222160551 ACCESSION NUMBER: 0001181431-12-010793 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120221 FILED AS OF DATE: 20120222 DATE AS OF CHANGE: 20120222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slichenmyer William CENTRAL INDEX KEY: 0001486428 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34655 FILM NUMBER: 12630350 MAIL ADDRESS: STREET 1: AVEO PHARMACEUTICALS, INC. STREET 2: 75 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001325879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 SIDNEY STREET STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172995000 MAIL ADDRESS: STREET 1: 75 SIDNEY STREET STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 rrd335326.xml SLICHENMYER FORM 4 X0304 4 2012-02-21 0 0001325879 AVEO PHARMACEUTICALS INC AVEO 0001486428 Slichenmyer William C/O AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Common Stock 2012-02-21 4 M 0 2000 9.64 A 25693 D Common Stock 2012-02-21 4 S 0 2000 13.6651 D 23693 D Stock Option (right to buy) 9.64 2012-02-21 4 M 0 2000 0 D 2019-10-08 Common Stock 2000 116500 D The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.55 to $13.78, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The option vested as to 25% of the shares on September 14, 2010 and thereafter vests in equal monthly installments as to the remaining shares through September 14, 2013. /s/ Joseph D. Vittiglio, attorney-in-fact 2012-02-22